nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—NR5A1—Vinblastine—germ cell cancer	0.391	0.668	CbGbCtD
Cladribine—ABCG2—Dactinomycin—germ cell cancer	0.047	0.0803	CbGbCtD
Cladribine—SLC22A2—Vinblastine—germ cell cancer	0.0399	0.0682	CbGbCtD
Cladribine—SLC22A2—Cisplatin—germ cell cancer	0.0366	0.0625	CbGbCtD
Cladribine—ABCG2—Cisplatin—germ cell cancer	0.027	0.0461	CbGbCtD
Cladribine—ABCG2—Etoposide—germ cell cancer	0.0265	0.0453	CbGbCtD
Cladribine—ABCG2—Methotrexate—germ cell cancer	0.0175	0.0299	CbGbCtD
Cladribine—NR5A1—seminiferous tubule of testis—germ cell cancer	0.0105	0.0876	CbGeAlD
Cladribine—NR5A1—Transcriptional regulation of pluripotent stem cells—TDGF1—germ cell cancer	0.0081	0.064	CbGpPWpGaD
Cladribine—NR5A1—Transcriptional regulation of pluripotent stem cells—SALL4—germ cell cancer	0.00688	0.0544	CbGpPWpGaD
Cladribine—NR5A1—Transcriptional regulation of pluripotent stem cells—NANOG—germ cell cancer	0.0066	0.0522	CbGpPWpGaD
Cladribine—NR5A1—Transcriptional regulation of pluripotent stem cells—POU5F1—germ cell cancer	0.00635	0.0502	CbGpPWpGaD
Cladribine—NR5A1—Transcriptional regulation of pluripotent stem cells—KLF4—germ cell cancer	0.005	0.0396	CbGpPWpGaD
Cladribine—NR5A1—Nuclear Receptors—NR0B1—germ cell cancer	0.00474	0.0375	CbGpPWpGaD
Cladribine—NR5A1—Ovarian Infertility Genes—INHA—germ cell cancer	0.00401	0.0317	CbGpPWpGaD
Cladribine—NR5A1—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00374	0.0296	CbGpPWpGaD
Cladribine—NR5A1—Transcriptional regulation of pluripotent stem cells—SOX2—germ cell cancer	0.00352	0.0279	CbGpPWpGaD
Cladribine—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00333	0.0263	CbGpPWpGaD
Cladribine—SLC22A2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00329	0.026	CbGpPWpGaD
Cladribine—SLC22A1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00307	0.0243	CbGpPWpGaD
Cladribine—RRM2B—ganglion—germ cell cancer	0.00303	0.0252	CbGeAlD
Cladribine—POLE4—embryo—germ cell cancer	0.0028	0.0233	CbGeAlD
Cladribine—POLE2—Global Genomic NER (GG-NER)—ERCC4—germ cell cancer	0.00274	0.0217	CbGpPWpGaD
Cladribine—POLE2—embryo—germ cell cancer	0.00244	0.0203	CbGeAlD
Cladribine—POLE2—Global Genomic NER (GG-NER)—ERCC1—germ cell cancer	0.0024	0.019	CbGpPWpGaD
Cladribine—SLC22A2—Organic cation transport—SLC22A3—germ cell cancer	0.00226	0.0179	CbGpPWpGaD
Cladribine—POLE2—Transcription-coupled NER (TC-NER)—ERCC4—germ cell cancer	0.00219	0.0173	CbGpPWpGaD
Cladribine—POLE4—skin of body—germ cell cancer	0.00217	0.018	CbGeAlD
Cladribine—SLC22A1—Organic cation transport—SLC22A3—germ cell cancer	0.00211	0.0167	CbGpPWpGaD
Cladribine—POLE2—Nucleotide Excision Repair—ERCC4—germ cell cancer	0.00201	0.0159	CbGpPWpGaD
Cladribine—POLE2—Teniposide—Etoposide—germ cell cancer	0.00197	0.557	CbGdCrCtD
Cladribine—POLE2—Transcription-coupled NER (TC-NER)—ERCC1—germ cell cancer	0.00192	0.0151	CbGpPWpGaD
Cladribine—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00191	0.0151	CbGpPWpGaD
Cladribine—SLC22A2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00189	0.015	CbGpPWpGaD
Cladribine—POLE—Global Genomic NER (GG-NER)—ERCC4—germ cell cancer	0.00177	0.014	CbGpPWpGaD
Cladribine—SLC22A1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00176	0.0139	CbGpPWpGaD
Cladribine—POLE2—Nucleotide Excision Repair—ERCC1—germ cell cancer	0.00176	0.0139	CbGpPWpGaD
Cladribine—RRM2—Vinorelbine—Vinblastine—germ cell cancer	0.00157	0.443	CbGdCrCtD
Cladribine—POLE—Global Genomic NER (GG-NER)—ERCC1—germ cell cancer	0.00154	0.0122	CbGpPWpGaD
Cladribine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00153	0.0121	CbGpPWpGaD
Cladribine—RRM2B—trigeminal ganglion—germ cell cancer	0.00149	0.0124	CbGeAlD
Cladribine—POLE2—adrenal gland—germ cell cancer	0.00145	0.012	CbGeAlD
Cladribine—POLE4—endocrine gland—germ cell cancer	0.00143	0.0119	CbGeAlD
Cladribine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00143	0.0113	CbGpPWpGaD
Cladribine—POLE4—head—germ cell cancer	0.00142	0.0118	CbGeAlD
Cladribine—POLE—Transcription-coupled NER (TC-NER)—ERCC4—germ cell cancer	0.00141	0.0112	CbGpPWpGaD
Cladribine—POLE3—trigeminal ganglion—germ cell cancer	0.00141	0.0117	CbGeAlD
Cladribine—POLE2—bone marrow—germ cell cancer	0.0014	0.0116	CbGeAlD
Cladribine—POLE3—embryo—germ cell cancer	0.00136	0.0113	CbGeAlD
Cladribine—POLE2—female gonad—germ cell cancer	0.00135	0.0112	CbGeAlD
Cladribine—POLE—Nucleotide Excision Repair—ERCC4—germ cell cancer	0.0013	0.0103	CbGpPWpGaD
Cladribine—RRM2B—eye—germ cell cancer	0.00128	0.0106	CbGeAlD
Cladribine—POLE—Transcription-coupled NER (TC-NER)—ERCC1—germ cell cancer	0.00123	0.00976	CbGpPWpGaD
Cladribine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00123	0.00969	CbGpPWpGaD
Cladribine—POLE3—eye—germ cell cancer	0.00121	0.0101	CbGeAlD
Cladribine—NR5A1—brainstem—germ cell cancer	0.0012	0.01	CbGeAlD
Cladribine—POLE2—testis—germ cell cancer	0.0012	0.00994	CbGeAlD
Cladribine—RRM2B—telencephalon—germ cell cancer	0.00117	0.00971	CbGeAlD
Cladribine—POLE—Nucleotide Excision Repair—ERCC1—germ cell cancer	0.00113	0.00897	CbGpPWpGaD
Cladribine—RRM2B—decidua—germ cell cancer	0.00111	0.0092	CbGeAlD
Cladribine—POLE3—telencephalon—germ cell cancer	0.0011	0.00917	CbGeAlD
Cladribine—POLE—trigeminal ganglion—germ cell cancer	0.00107	0.00891	CbGeAlD
Cladribine—POLE2—DNA Repair—ERCC4—germ cell cancer	0.00105	0.0083	CbGpPWpGaD
Cladribine—POLE3—decidua—germ cell cancer	0.00105	0.0087	CbGeAlD
Cladribine—PNP—uterus—germ cell cancer	0.00104	0.00867	CbGeAlD
Cladribine—POLE—embryo—germ cell cancer	0.00104	0.00861	CbGeAlD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.00103	0.00813	CbGpPWpGaD
Cladribine—POLE4—brain—germ cell cancer	0.00103	0.00853	CbGeAlD
Cladribine—SLC22A1—ganglion—germ cell cancer	0.000989	0.00822	CbGeAlD
Cladribine—RRM2B—pituitary gland—germ cell cancer	0.00095	0.0079	CbGeAlD
Cladribine—POLA1—trigeminal ganglion—germ cell cancer	0.000924	0.00768	CbGeAlD
Cladribine—POLE3—gonad—germ cell cancer	0.000921	0.00766	CbGeAlD
Cladribine—RRM2B—medulla oblongata—germ cell cancer	0.000917	0.00763	CbGeAlD
Cladribine—POLE2—DNA Repair—ERCC1—germ cell cancer	0.000917	0.00725	CbGpPWpGaD
Cladribine—POLE3—pituitary gland—germ cell cancer	0.000899	0.00747	CbGeAlD
Cladribine—NR5A1—gonad—germ cell cancer	0.000892	0.00742	CbGeAlD
Cladribine—PNP—bone marrow—germ cell cancer	0.000885	0.00736	CbGeAlD
Cladribine—NR5A1—pituitary gland—germ cell cancer	0.000871	0.00724	CbGeAlD
Cladribine—POLE3—medulla oblongata—germ cell cancer	0.000867	0.00721	CbGeAlD
Cladribine—POLE2—lymph node—germ cell cancer	0.000867	0.00721	CbGeAlD
Cladribine—PNP—female gonad—germ cell cancer	0.000853	0.00709	CbGeAlD
Cladribine—RRM2—embryo—germ cell cancer	0.000852	0.00709	CbGeAlD
Cladribine—RRM2B—adrenal gland—germ cell cancer	0.000849	0.00706	CbGeAlD
Cladribine—RRM2B—midbrain—germ cell cancer	0.000838	0.00697	CbGeAlD
Cladribine—RRM2B—bone marrow—germ cell cancer	0.000821	0.00683	CbGeAlD
Cladribine—RRM2B—spinal cord—germ cell cancer	0.000818	0.0068	CbGeAlD
Cladribine—POLE3—adrenal gland—germ cell cancer	0.000803	0.00667	CbGeAlD
Cladribine—POLE—decidua—germ cell cancer	0.000798	0.00663	CbGeAlD
Cladribine—PNP—endocrine gland—germ cell cancer	0.000793	0.00659	CbGeAlD
Cladribine—POLE3—midbrain—germ cell cancer	0.000792	0.00659	CbGeAlD
Cladribine—RRM2B—female gonad—germ cell cancer	0.000792	0.00658	CbGeAlD
Cladribine—POLA1—retina—germ cell cancer	0.000789	0.00656	CbGeAlD
Cladribine—PNP—head—germ cell cancer	0.000783	0.00651	CbGeAlD
Cladribine—NR5A1—adrenal gland—germ cell cancer	0.000778	0.00647	CbGeAlD
Cladribine—POLE3—bone marrow—germ cell cancer	0.000777	0.00646	CbGeAlD
Cladribine—POLE3—spinal cord—germ cell cancer	0.000773	0.00643	CbGeAlD
Cladribine—POLE2—Telomere Maintenance—H2AFZ—germ cell cancer	0.000767	0.00606	CbGpPWpGaD
Cladribine—POLE3—female gonad—germ cell cancer	0.000748	0.00622	CbGeAlD
Cladribine—RRM2B—endocrine gland—germ cell cancer	0.000736	0.00612	CbGeAlD
Cladribine—RRM1—trigeminal ganglion—germ cell cancer	0.000733	0.0061	CbGeAlD
Cladribine—RRM2B—head—germ cell cancer	0.000727	0.00604	CbGeAlD
Cladribine—SLC28A3—bone marrow—germ cell cancer	0.000727	0.00604	CbGeAlD
Cladribine—NR5A1—female gonad—germ cell cancer	0.000725	0.00603	CbGeAlD
Cladribine—POLE—gonad—germ cell cancer	0.000703	0.00584	CbGeAlD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000702	0.00555	CbGpPWpGaD
Cladribine—RRM2B—testis—germ cell cancer	0.000702	0.00584	CbGeAlD
Cladribine—SLC28A3—female gonad—germ cell cancer	0.0007	0.00582	CbGeAlD
Cladribine—POLE3—endocrine gland—germ cell cancer	0.000696	0.00579	CbGeAlD
Cladribine—POLA1—decidua—germ cell cancer	0.000688	0.00572	CbGeAlD
Cladribine—SLC22A2—trigeminal ganglion—germ cell cancer	0.000688	0.00572	CbGeAlD
Cladribine—POLE3—head—germ cell cancer	0.000687	0.00571	CbGeAlD
Cladribine—POLE—pituitary gland—germ cell cancer	0.000685	0.0057	CbGeAlD
Cladribine—POLE—DNA Repair—ERCC4—germ cell cancer	0.000676	0.00535	CbGpPWpGaD
Cladribine—NR5A1—endocrine gland—germ cell cancer	0.000674	0.00561	CbGeAlD
Cladribine—NR5A1—head—germ cell cancer	0.000666	0.00554	CbGeAlD
Cladribine—POLE3—testis—germ cell cancer	0.000664	0.00552	CbGeAlD
Cladribine—RRM2—skin of body—germ cell cancer	0.000662	0.0055	CbGeAlD
Cladribine—RRM2—decidua—germ cell cancer	0.000657	0.00546	CbGeAlD
Cladribine—RRM2B—cerebellum—germ cell cancer	0.000649	0.00539	CbGeAlD
Cladribine—NR5A1—Developmental Biology—TDGF1—germ cell cancer	0.000647	0.00512	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000647	0.00511	CbGpPWpGaD
Cladribine—NR5A1—testis—germ cell cancer	0.000643	0.00535	CbGeAlD
Cladribine—POLE2—Chromosome Maintenance—H2AFZ—germ cell cancer	0.000639	0.00505	CbGpPWpGaD
Cladribine—RRM1—eye—germ cell cancer	0.000632	0.00525	CbGeAlD
Cladribine—RRM1—retina—germ cell cancer	0.000626	0.00521	CbGeAlD
Cladribine—POLE3—cerebellum—germ cell cancer	0.000613	0.0051	CbGeAlD
Cladribine—POLE—adrenal gland—germ cell cancer	0.000612	0.00509	CbGeAlD
Cladribine—NR5A1—cerebellum—germ cell cancer	0.000594	0.00494	CbGeAlD
Cladribine—POLE—bone marrow—germ cell cancer	0.000592	0.00493	CbGeAlD
Cladribine—POLE—DNA Repair—ERCC1—germ cell cancer	0.000591	0.00467	CbGpPWpGaD
Cladribine—POLA1—pituitary gland—germ cell cancer	0.000591	0.00491	CbGeAlD
Cladribine—RRM2—gonad—germ cell cancer	0.000579	0.00481	CbGeAlD
Cladribine—RRM1—telencephalon—germ cell cancer	0.000576	0.00479	CbGeAlD
Cladribine—RRM2—uterus—germ cell cancer	0.000575	0.00478	CbGeAlD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000573	0.00453	CbGpPWpGaD
Cladribine—POLE—female gonad—germ cell cancer	0.000571	0.00475	CbGeAlD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00057	0.00451	CbGpPWpGaD
Cladribine—DCK—trigeminal ganglion—germ cell cancer	0.00057	0.00474	CbGeAlD
Cladribine—PNP—brain—germ cell cancer	0.000567	0.00472	CbGeAlD
Cladribine—RRM2—pituitary gland—germ cell cancer	0.000564	0.00469	CbGeAlD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000562	0.00444	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—SALL4—germ cell cancer	0.00055	0.00435	CbGpPWpGaD
Cladribine—DCK—embryo—germ cell cancer	0.00055	0.00457	CbGeAlD
Cladribine—RRM1—skin of body—germ cell cancer	0.00055	0.00457	CbGeAlD
Cladribine—RRM1—decidua—germ cell cancer	0.000546	0.00454	CbGeAlD
Cladribine—POLE—endocrine gland—germ cell cancer	0.000531	0.00441	CbGeAlD
Cladribine—POLA1—adrenal gland—germ cell cancer	0.000528	0.00439	CbGeAlD
Cladribine—NR5A1—Developmental Biology—NANOG—germ cell cancer	0.000528	0.00417	CbGpPWpGaD
Cladribine—RRM2B—brain—germ cell cancer	0.000527	0.00438	CbGeAlD
Cladribine—POLE—head—germ cell cancer	0.000524	0.00436	CbGeAlD
Cladribine—POLA1—bone marrow—germ cell cancer	0.000511	0.00424	CbGeAlD
Cladribine—RRM2B—lymph node—germ cell cancer	0.000509	0.00423	CbGeAlD
Cladribine—NR5A1—Developmental Biology—POU5F1—germ cell cancer	0.000508	0.00402	CbGpPWpGaD
Cladribine—POLE—testis—germ cell cancer	0.000506	0.00421	CbGeAlD
Cladribine—RRM2—adrenal gland—germ cell cancer	0.000504	0.00419	CbGeAlD
Cladribine—POLE3—brain—germ cell cancer	0.000498	0.00414	CbGeAlD
Cladribine—POLE—Telomere Maintenance—H2AFZ—germ cell cancer	0.000494	0.00391	CbGpPWpGaD
Cladribine—POLA1—female gonad—germ cell cancer	0.000492	0.00409	CbGeAlD
Cladribine—RRM2—bone marrow—germ cell cancer	0.000488	0.00406	CbGeAlD
Cladribine—DCK—retina—germ cell cancer	0.000486	0.00404	CbGeAlD
Cladribine—RRM2B—DNA Damage Response—MYC—germ cell cancer	0.000484	0.00382	CbGpPWpGaD
Cladribine—NR5A1—brain—germ cell cancer	0.000483	0.00401	CbGeAlD
Cladribine—POLE3—lymph node—germ cell cancer	0.000481	0.004	CbGeAlD
Cladribine—RRM1—gonad—germ cell cancer	0.000481	0.004	CbGeAlD
Cladribine—RRM1—uterus—germ cell cancer	0.000478	0.00397	CbGeAlD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000472	0.00373	CbGpPWpGaD
Cladribine—RRM2—female gonad—germ cell cancer	0.00047	0.00391	CbGeAlD
Cladribine—RRM1—pituitary gland—germ cell cancer	0.000469	0.0039	CbGeAlD
Cladribine—POLE—cerebellum—germ cell cancer	0.000468	0.00389	CbGeAlD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—MYC—germ cell cancer	0.000467	0.0037	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000453	0.00358	CbGpPWpGaD
Cladribine—RRM1—medulla oblongata—germ cell cancer	0.000453	0.00376	CbGeAlD
Cladribine—DCK—telencephalon—germ cell cancer	0.000447	0.00372	CbGeAlD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000443	0.0035	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000441	0.00348	CbGpPWpGaD
Cladribine—RRM2—endocrine gland—germ cell cancer	0.000437	0.00364	CbGeAlD
Cladribine—POLA1—testis—germ cell cancer	0.000436	0.00363	CbGeAlD
Cladribine—RRM2—head—germ cell cancer	0.000432	0.00359	CbGeAlD
Cladribine—DCK—decidua—germ cell cancer	0.000424	0.00353	CbGeAlD
Cladribine—RRM1—adrenal gland—germ cell cancer	0.000419	0.00348	CbGeAlD
Cladribine—RRM2—testis—germ cell cancer	0.000417	0.00347	CbGeAlD
Cladribine—RRM1—midbrain—germ cell cancer	0.000414	0.00344	CbGeAlD
Cladribine—POLE—Chromosome Maintenance—H2AFZ—germ cell cancer	0.000412	0.00325	CbGpPWpGaD
Cladribine—RRM1—bone marrow—germ cell cancer	0.000405	0.00337	CbGeAlD
Cladribine—RRM1—spinal cord—germ cell cancer	0.000404	0.00335	CbGeAlD
Cladribine—POLA1—cerebellum—germ cell cancer	0.000403	0.00335	CbGeAlD
Cladribine—NR5A1—Developmental Biology—KLF4—germ cell cancer	0.0004	0.00316	CbGpPWpGaD
Cladribine—RRM2B—DNA Damage Response—TP53—germ cell cancer	0.000397	0.00314	CbGpPWpGaD
Cladribine—RRM1—female gonad—germ cell cancer	0.000391	0.00325	CbGeAlD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—TP53—germ cell cancer	0.000384	0.00303	CbGpPWpGaD
Cladribine—SLC22A1—telencephalon—germ cell cancer	0.000382	0.00317	CbGeAlD
Cladribine—POLE—brain—germ cell cancer	0.00038	0.00316	CbGeAlD
Cladribine—DCK—gonad—germ cell cancer	0.000373	0.0031	CbGeAlD
Cladribine—DCK—uterus—germ cell cancer	0.000371	0.00308	CbGeAlD
Cladribine—POLE—lymph node—germ cell cancer	0.000367	0.00305	CbGeAlD
Cladribine—DCK—pituitary gland—germ cell cancer	0.000364	0.00303	CbGeAlD
Cladribine—RRM1—endocrine gland—germ cell cancer	0.000363	0.00302	CbGeAlD
Cladribine—RRM1—head—germ cell cancer	0.000359	0.00298	CbGeAlD
Cladribine—RRM1—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000353	0.00279	CbGpPWpGaD
Cladribine—POLA1—Telomere Maintenance—H2AFZ—germ cell cancer	0.000352	0.00278	CbGpPWpGaD
Cladribine—DCK—medulla oblongata—germ cell cancer	0.000351	0.00292	CbGeAlD
Cladribine—RRM1—testis—germ cell cancer	0.000346	0.00288	CbGeAlD
Cladribine—POLA1—brain—germ cell cancer	0.000327	0.00272	CbGeAlD
Cladribine—DCK—adrenal gland—germ cell cancer	0.000325	0.00271	CbGeAlD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000323	0.00255	CbGpPWpGaD
Cladribine—DCK—midbrain—germ cell cancer	0.000321	0.00267	CbGeAlD
Cladribine—RRM1—cerebellum—germ cell cancer	0.00032	0.00266	CbGeAlD
Cladribine—ABCG2—trigeminal ganglion—germ cell cancer	0.000318	0.00264	CbGeAlD
Cladribine—POLA1—lymph node—germ cell cancer	0.000316	0.00263	CbGeAlD
Cladribine—DCK—bone marrow—germ cell cancer	0.000315	0.00262	CbGeAlD
Cladribine—DCK—spinal cord—germ cell cancer	0.000313	0.00261	CbGeAlD
Cladribine—RRM2—brain—germ cell cancer	0.000313	0.0026	CbGeAlD
Cladribine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000312	0.00247	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NR0B1—germ cell cancer	0.000311	0.00246	CbGpPWpGaD
Cladribine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000307	0.00243	CbGpPWpGaD
Cladribine—DCK—female gonad—germ cell cancer	0.000303	0.00252	CbGeAlD
Cladribine—RRM2—lymph node—germ cell cancer	0.000302	0.00251	CbGeAlD
Cladribine—POLE2—G1 to S cell cycle control—MYC—germ cell cancer	0.000295	0.00234	CbGpPWpGaD
Cladribine—POLA1—Chromosome Maintenance—H2AFZ—germ cell cancer	0.000293	0.00232	CbGpPWpGaD
Cladribine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000291	0.0023	CbGpPWpGaD
Cladribine—RRM2—Fluoropyrimidine Activity—TP53—germ cell cancer	0.00029	0.0023	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.00029	0.00229	CbGpPWpGaD
Cladribine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000286	0.00226	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000286	0.00226	CbGpPWpGaD
Cladribine—DCK—endocrine gland—germ cell cancer	0.000282	0.00235	CbGeAlD
Cladribine—NR5A1—Developmental Biology—SOX2—germ cell cancer	0.000282	0.00223	CbGpPWpGaD
Cladribine—DCK—head—germ cell cancer	0.000279	0.00232	CbGeAlD
Cladribine—NR5A1—Gene Expression—DNMT3L—germ cell cancer	0.00027	0.00213	CbGpPWpGaD
Cladribine—DCK—testis—germ cell cancer	0.000269	0.00224	CbGeAlD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000263	0.00208	CbGpPWpGaD
Cladribine—RRM1—brain—germ cell cancer	0.00026	0.00216	CbGeAlD
Cladribine—RRM1—lymph node—germ cell cancer	0.000251	0.00209	CbGeAlD
Cladribine—NR5A1—Gene Expression—RARS—germ cell cancer	0.000251	0.00198	CbGpPWpGaD
Cladribine—ABCG2—telencephalon—germ cell cancer	0.00025	0.00207	CbGeAlD
Cladribine—DCK—cerebellum—germ cell cancer	0.000249	0.00207	CbGeAlD
Cladribine—POLE2—G1 to S cell cycle control—TP53—germ cell cancer	0.000243	0.00192	CbGpPWpGaD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000243	0.00192	CbGpPWpGaD
Cladribine—POLE2—Mitotic M-M/G1 phases—H2AFZ—germ cell cancer	0.000242	0.00192	CbGpPWpGaD
Cladribine—SLC22A1—endocrine gland—germ cell cancer	0.000241	0.002	CbGeAlD
Cladribine—SLC22A1—head—germ cell cancer	0.000238	0.00198	CbGeAlD
Cladribine—ABCG2—decidua—germ cell cancer	0.000237	0.00197	CbGeAlD
Cladribine—RRM1—E2F transcription factor network—MYC—germ cell cancer	0.000228	0.0018	CbGpPWpGaD
Cladribine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000226	0.00138	CcSEcCtD
Cladribine—Anaemia—Ifosfamide—germ cell cancer	0.000226	0.00138	CcSEcCtD
Cladribine—Cardiac disorder—Cisplatin—germ cell cancer	0.000225	0.00137	CcSEcCtD
Cladribine—Discomfort—Dactinomycin—germ cell cancer	0.000225	0.00137	CcSEcCtD
Cladribine—RRM2B—Direct p53 effectors—TP53—germ cell cancer	0.000223	0.00176	CbGpPWpGaD
Cladribine—Anorexia—Bleomycin—germ cell cancer	0.000223	0.00136	CcSEcCtD
Cladribine—RRM2B—Metabolism—SLC2A3—germ cell cancer	0.000222	0.00176	CbGpPWpGaD
Cladribine—Malaise—Ifosfamide—germ cell cancer	0.000221	0.00135	CcSEcCtD
Cladribine—Urinary tract disorder—Etoposide—germ cell cancer	0.000219	0.00134	CcSEcCtD
Cladribine—Immune system disorder—Cisplatin—germ cell cancer	0.000219	0.00133	CcSEcCtD
Cladribine—RRM2B—Metabolism—SLC22A3—germ cell cancer	0.000219	0.00173	CbGpPWpGaD
Cladribine—Abdominal pain—Vinblastine—germ cell cancer	0.000219	0.00133	CcSEcCtD
Cladribine—Mediastinal disorder—Cisplatin—germ cell cancer	0.000219	0.00133	CcSEcCtD
Cladribine—Hypotension—Bleomycin—germ cell cancer	0.000218	0.00133	CcSEcCtD
Cladribine—Oedema—Dactinomycin—germ cell cancer	0.000218	0.00133	CcSEcCtD
Cladribine—Urethral disorder—Etoposide—germ cell cancer	0.000218	0.00133	CcSEcCtD
Cladribine—Infection—Dactinomycin—germ cell cancer	0.000217	0.00132	CcSEcCtD
Cladribine—Arrhythmia—Cisplatin—germ cell cancer	0.000217	0.00132	CcSEcCtD
Cladribine—Alopecia—Cisplatin—germ cell cancer	0.000214	0.00131	CcSEcCtD
Cladribine—Hepatic failure—Methotrexate—germ cell cancer	0.000214	0.0013	CcSEcCtD
Cladribine—Cough—Ifosfamide—germ cell cancer	0.000214	0.0013	CcSEcCtD
Cladribine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000213	0.0013	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000213	0.0013	CcSEcCtD
Cladribine—Erythema—Cisplatin—germ cell cancer	0.000211	0.00129	CcSEcCtD
Cladribine—Malnutrition—Cisplatin—germ cell cancer	0.000211	0.00129	CcSEcCtD
Cladribine—Erythema multiforme—Etoposide—germ cell cancer	0.00021	0.00128	CcSEcCtD
Cladribine—Paraesthesia—Bleomycin—germ cell cancer	0.00021	0.00128	CcSEcCtD
Cladribine—Dyspnoea—Bleomycin—germ cell cancer	0.000208	0.00127	CcSEcCtD
Cladribine—Arthralgia—Ifosfamide—germ cell cancer	0.000208	0.00127	CcSEcCtD
Cladribine—Chest pain—Ifosfamide—germ cell cancer	0.000208	0.00127	CcSEcCtD
Cladribine—Myalgia—Ifosfamide—germ cell cancer	0.000208	0.00127	CcSEcCtD
Cladribine—Renal failure acute—Methotrexate—germ cell cancer	0.000208	0.00127	CcSEcCtD
Cladribine—Flatulence—Cisplatin—germ cell cancer	0.000208	0.00127	CcSEcCtD
Cladribine—Anorexia—Dactinomycin—germ cell cancer	0.000208	0.00127	CcSEcCtD
Cladribine—Eye disorder—Etoposide—germ cell cancer	0.000208	0.00126	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000207	0.00126	CcSEcCtD
Cladribine—ABCG2—uterus—germ cell cancer	0.000207	0.00172	CbGeAlD
Cladribine—Cardiac disorder—Etoposide—germ cell cancer	0.000206	0.00126	CcSEcCtD
Cladribine—Discomfort—Ifosfamide—germ cell cancer	0.000206	0.00125	CcSEcCtD
Cladribine—Hypersensitivity—Vinblastine—germ cell cancer	0.000204	0.00124	CcSEcCtD
Cladribine—Decreased appetite—Bleomycin—germ cell cancer	0.000203	0.00124	CcSEcCtD
Cladribine—ABCG2—pituitary gland—germ cell cancer	0.000203	0.00169	CbGeAlD
Cladribine—POLE2—G1/S Transition—MYC—germ cell cancer	0.000203	0.0016	CbGpPWpGaD
Cladribine—DCK—brain—germ cell cancer	0.000202	0.00168	CbGeAlD
Cladribine—Angiopathy—Etoposide—germ cell cancer	0.000202	0.00123	CcSEcCtD
Cladribine—Confusional state—Ifosfamide—germ cell cancer	0.000201	0.00123	CcSEcCtD
Cladribine—Immune system disorder—Etoposide—germ cell cancer	0.000201	0.00122	CcSEcCtD
Cladribine—Mediastinal disorder—Etoposide—germ cell cancer	0.0002	0.00122	CcSEcCtD
Cladribine—Pain—Bleomycin—germ cell cancer	0.0002	0.00122	CcSEcCtD
Cladribine—Oedema—Ifosfamide—germ cell cancer	0.0002	0.00122	CcSEcCtD
Cladribine—Chills—Etoposide—germ cell cancer	0.000199	0.00121	CcSEcCtD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	0.000199	0.00158	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000199	0.00121	CcSEcCtD
Cladribine—Asthenia—Vinblastine—germ cell cancer	0.000199	0.00121	CcSEcCtD
Cladribine—Infection—Ifosfamide—germ cell cancer	0.000198	0.00121	CcSEcCtD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000198	0.00156	CbGpPWpGaD
Cladribine—Alopecia—Etoposide—germ cell cancer	0.000196	0.0012	CcSEcCtD
Cladribine—Lethargy—Methotrexate—germ cell cancer	0.000196	0.0012	CcSEcCtD
Cladribine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000196	0.0012	CcSEcCtD
Cladribine—ABCG2—medulla oblongata—germ cell cancer	0.000196	0.00163	CbGeAlD
Cladribine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000196	0.00119	CcSEcCtD
Cladribine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000196	0.00119	CcSEcCtD
Cladribine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000196	0.00119	CcSEcCtD
Cladribine—Anaemia—Cisplatin—germ cell cancer	0.000195	0.00119	CcSEcCtD
Cladribine—DCK—lymph node—germ cell cancer	0.000195	0.00162	CbGeAlD
Cladribine—Skin disorder—Ifosfamide—germ cell cancer	0.000194	0.00118	CcSEcCtD
Cladribine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000193	0.00118	CcSEcCtD
Cladribine—PNP—Metabolism—SLC2A3—germ cell cancer	0.000193	0.00152	CbGpPWpGaD
Cladribine—Feeling abnormal—Bleomycin—germ cell cancer	0.000193	0.00117	CcSEcCtD
Cladribine—Anorexia—Ifosfamide—germ cell cancer	0.00019	0.00116	CcSEcCtD
Cladribine—POLE—G1 to S cell cycle control—MYC—germ cell cancer	0.00019	0.00151	CbGpPWpGaD
Cladribine—Malaise—Cisplatin—germ cell cancer	0.00019	0.00116	CcSEcCtD
Cladribine—PNP—Metabolism—SLC22A3—germ cell cancer	0.00019	0.0015	CbGpPWpGaD
Cladribine—Decreased appetite—Dactinomycin—germ cell cancer	0.00019	0.00115	CcSEcCtD
Cladribine—Diarrhoea—Vinblastine—germ cell cancer	0.000189	0.00115	CcSEcCtD
Cladribine—Fatigue—Dactinomycin—germ cell cancer	0.000188	0.00115	CcSEcCtD
Cladribine—RRM2—E2F transcription factor network—MYC—germ cell cancer	0.000187	0.00148	CbGpPWpGaD
Cladribine—Back pain—Etoposide—germ cell cancer	0.000187	0.00114	CcSEcCtD
Cladribine—Hypotension—Ifosfamide—germ cell cancer	0.000187	0.00114	CcSEcCtD
Cladribine—Pain—Dactinomycin—germ cell cancer	0.000186	0.00114	CcSEcCtD
Cladribine—Urticaria—Bleomycin—germ cell cancer	0.000186	0.00113	CcSEcCtD
Cladribine—Body temperature increased—Bleomycin—germ cell cancer	0.000185	0.00113	CcSEcCtD
Cladribine—POLE2—S Phase—MYC—germ cell cancer	0.000184	0.00145	CbGpPWpGaD
Cladribine—Dizziness—Vinblastine—germ cell cancer	0.000183	0.00112	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000182	0.00111	CcSEcCtD
Cladribine—ABCG2—adrenal gland—germ cell cancer	0.000182	0.00151	CbGeAlD
Cladribine—POLE2—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	0.000181	0.00143	CbGpPWpGaD
Cladribine—Ataxia—Methotrexate—germ cell cancer	0.000181	0.0011	CcSEcCtD
Cladribine—Myalgia—Cisplatin—germ cell cancer	0.00018	0.00109	CcSEcCtD
Cladribine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00018	0.00109	CcSEcCtD
Cladribine—Paraesthesia—Ifosfamide—germ cell cancer	0.000179	0.00109	CcSEcCtD
Cladribine—Ill-defined disorder—Etoposide—germ cell cancer	0.000179	0.00109	CcSEcCtD
Cladribine—ABCG2—midbrain—germ cell cancer	0.000179	0.00149	CbGeAlD
Cladribine—Anxiety—Cisplatin—germ cell cancer	0.000179	0.00109	CcSEcCtD
Cladribine—Anaemia—Etoposide—germ cell cancer	0.000179	0.00109	CcSEcCtD
Cladribine—RRM2B—Metabolism—CRABP1—germ cell cancer	0.000178	0.00141	CbGpPWpGaD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000178	0.00109	CcSEcCtD
Cladribine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000178	0.00109	CcSEcCtD
Cladribine—Dyspnoea—Ifosfamide—germ cell cancer	0.000178	0.00109	CcSEcCtD
Cladribine—Somnolence—Ifosfamide—germ cell cancer	0.000178	0.00108	CcSEcCtD
Cladribine—Discomfort—Cisplatin—germ cell cancer	0.000178	0.00108	CcSEcCtD
Cladribine—Vomiting—Vinblastine—germ cell cancer	0.000176	0.00107	CcSEcCtD
Cladribine—ABCG2—bone marrow—germ cell cancer	0.000176	0.00146	CbGeAlD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000175	0.00139	CbGpPWpGaD
Cladribine—ABCG2—spinal cord—germ cell cancer	0.000175	0.00145	CbGeAlD
Cladribine—Malaise—Etoposide—germ cell cancer	0.000174	0.00106	CcSEcCtD
Cladribine—Decreased appetite—Ifosfamide—germ cell cancer	0.000174	0.00106	CcSEcCtD
Cladribine—Headache—Vinblastine—germ cell cancer	0.000173	0.00106	CcSEcCtD
Cladribine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000173	0.00106	CcSEcCtD
Cladribine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000172	0.00105	CcSEcCtD
Cladribine—Body temperature increased—Dactinomycin—germ cell cancer	0.000172	0.00105	CcSEcCtD
Cladribine—Abdominal pain—Dactinomycin—germ cell cancer	0.000172	0.00105	CcSEcCtD
Cladribine—Fatigue—Ifosfamide—germ cell cancer	0.000172	0.00105	CcSEcCtD
Cladribine—Oedema—Cisplatin—germ cell cancer	0.000172	0.00105	CcSEcCtD
Cladribine—Hypersensitivity—Bleomycin—germ cell cancer	0.000172	0.00105	CcSEcCtD
Cladribine—SLC22A1—brain—germ cell cancer	0.000172	0.00143	CbGeAlD
Cladribine—Infection—Cisplatin—germ cell cancer	0.000171	0.00104	CcSEcCtD
Cladribine—Constipation—Ifosfamide—germ cell cancer	0.000171	0.00104	CcSEcCtD
Cladribine—Pain—Ifosfamide—germ cell cancer	0.000171	0.00104	CcSEcCtD
Cladribine—POLE2—Mitotic G1-G1/S phases—MYC—germ cell cancer	0.000171	0.00135	CbGpPWpGaD
Cladribine—ABCG2—female gonad—germ cell cancer	0.000169	0.00141	CbGeAlD
Cladribine—Nervous system disorder—Cisplatin—germ cell cancer	0.000169	0.00103	CcSEcCtD
Cladribine—Cough—Etoposide—germ cell cancer	0.000169	0.00103	CcSEcCtD
Cladribine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000169	0.00103	CcSEcCtD
Cladribine—Tachycardia—Cisplatin—germ cell cancer	0.000168	0.00102	CcSEcCtD
Cladribine—Asthenia—Bleomycin—germ cell cancer	0.000168	0.00102	CcSEcCtD
Cladribine—Skin disorder—Cisplatin—germ cell cancer	0.000167	0.00102	CcSEcCtD
Cladribine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000167	0.00101	CcSEcCtD
Cladribine—Pruritus—Bleomycin—germ cell cancer	0.000165	0.00101	CcSEcCtD
Cladribine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000165	0.001	CcSEcCtD
Cladribine—Chest pain—Etoposide—germ cell cancer	0.000165	0.001	CcSEcCtD
Cladribine—Eosinophilia—Methotrexate—germ cell cancer	0.000165	0.001	CcSEcCtD
Cladribine—Nausea—Vinblastine—germ cell cancer	0.000164	0.001	CcSEcCtD
Cladribine—Anorexia—Cisplatin—germ cell cancer	0.000164	0.001	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000163	0.000996	CcSEcCtD
Cladribine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000163	0.000996	CcSEcCtD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000163	0.00129	CbGpPWpGaD
Cladribine—Discomfort—Etoposide—germ cell cancer	0.000163	0.000991	CcSEcCtD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	0.000162	0.00128	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—H2AFZ—germ cell cancer	0.000162	0.00128	CbGpPWpGaD
Cladribine—Hypotension—Cisplatin—germ cell cancer	0.000161	0.000981	CcSEcCtD
Cladribine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000161	0.000979	CcSEcCtD
Cladribine—Abdominal discomfort—Methotrexate—germ cell cancer	0.000159	0.000971	CcSEcCtD
Cladribine—Confusional state—Etoposide—germ cell cancer	0.000159	0.00097	CcSEcCtD
Cladribine—Urticaria—Ifosfamide—germ cell cancer	0.000159	0.000967	CcSEcCtD
Cladribine—Body temperature increased—Ifosfamide—germ cell cancer	0.000158	0.000962	CcSEcCtD
Cladribine—Abdominal pain—Ifosfamide—germ cell cancer	0.000158	0.000962	CcSEcCtD
Cladribine—Pancytopenia—Methotrexate—germ cell cancer	0.000158	0.000962	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000157	0.000956	CcSEcCtD
Cladribine—Infection—Etoposide—germ cell cancer	0.000157	0.000955	CcSEcCtD
Cladribine—Asthenia—Dactinomycin—germ cell cancer	0.000156	0.000953	CcSEcCtD
Cladribine—POLE—G1 to S cell cycle control—TP53—germ cell cancer	0.000156	0.00124	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000156	0.00124	CbGpPWpGaD
Cladribine—POLE—Mitotic M-M/G1 phases—H2AFZ—germ cell cancer	0.000156	0.00123	CbGpPWpGaD
Cladribine—Neutropenia—Methotrexate—germ cell cancer	0.000155	0.000947	CcSEcCtD
Cladribine—PNP—Metabolism—CRABP1—germ cell cancer	0.000155	0.00122	CbGpPWpGaD
Cladribine—Paraesthesia—Cisplatin—germ cell cancer	0.000155	0.000942	CcSEcCtD
Cladribine—Thrombocytopenia—Etoposide—germ cell cancer	0.000155	0.000941	CcSEcCtD
Cladribine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000154	0.000941	CcSEcCtD
Cladribine—Tachycardia—Etoposide—germ cell cancer	0.000154	0.000938	CcSEcCtD
Cladribine—Dyspnoea—Cisplatin—germ cell cancer	0.000154	0.000936	CcSEcCtD
Cladribine—Skin disorder—Etoposide—germ cell cancer	0.000153	0.000934	CcSEcCtD
Cladribine—Hyperhidrosis—Etoposide—germ cell cancer	0.000153	0.00093	CcSEcCtD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000152	0.0012	CbGpPWpGaD
Cladribine—Anorexia—Etoposide—germ cell cancer	0.00015	0.000917	CcSEcCtD
Cladribine—ABCG2—testis—germ cell cancer	0.00015	0.00125	CbGeAlD
Cladribine—Decreased appetite—Cisplatin—germ cell cancer	0.00015	0.000912	CcSEcCtD
Cladribine—Diarrhoea—Dactinomycin—germ cell cancer	0.000149	0.000909	CcSEcCtD
Cladribine—Pneumonia—Methotrexate—germ cell cancer	0.000149	0.000908	CcSEcCtD
Cladribine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000149	0.000906	CcSEcCtD
Cladribine—Vomiting—Bleomycin—germ cell cancer	0.000149	0.000906	CcSEcCtD
Cladribine—Infestation NOS—Methotrexate—germ cell cancer	0.000148	0.000903	CcSEcCtD
Cladribine—Infestation—Methotrexate—germ cell cancer	0.000148	0.000903	CcSEcCtD
Cladribine—Hypotension—Etoposide—germ cell cancer	0.000147	0.000899	CcSEcCtD
Cladribine—Rash—Bleomycin—germ cell cancer	0.000147	0.000898	CcSEcCtD
Cladribine—Pain—Cisplatin—germ cell cancer	0.000147	0.000898	CcSEcCtD
Cladribine—Dermatitis—Bleomycin—germ cell cancer	0.000147	0.000897	CcSEcCtD
Cladribine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000147	0.000897	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000147	0.000895	CcSEcCtD
Cladribine—Renal failure—Methotrexate—germ cell cancer	0.000146	0.000888	CcSEcCtD
Cladribine—Conjunctivitis—Methotrexate—germ cell cancer	0.000144	0.000878	CcSEcCtD
Cladribine—Asthenia—Ifosfamide—germ cell cancer	0.000143	0.000874	CcSEcCtD
Cladribine—Feeling abnormal—Cisplatin—germ cell cancer	0.000142	0.000865	CcSEcCtD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000142	0.00112	CbGpPWpGaD
Cladribine—Paraesthesia—Etoposide—germ cell cancer	0.000142	0.000863	CcSEcCtD
Cladribine—Pruritus—Ifosfamide—germ cell cancer	0.000141	0.000861	CcSEcCtD
Cladribine—Dyspnoea—Etoposide—germ cell cancer	0.000141	0.000857	CcSEcCtD
Cladribine—Somnolence—Etoposide—germ cell cancer	0.00014	0.000855	CcSEcCtD
Cladribine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00014	0.000854	CcSEcCtD
Cladribine—Epistaxis—Methotrexate—germ cell cancer	0.00014	0.000852	CcSEcCtD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00014	0.0011	CbGpPWpGaD
Cladribine—Nausea—Bleomycin—germ cell cancer	0.000139	0.000846	CcSEcCtD
Cladribine—ABCG2—cerebellum—germ cell cancer	0.000139	0.00115	CbGeAlD
Cladribine—Vomiting—Dactinomycin—germ cell cancer	0.000139	0.000845	CcSEcCtD
Cladribine—Rash—Dactinomycin—germ cell cancer	0.000137	0.000838	CcSEcCtD
Cladribine—Decreased appetite—Etoposide—germ cell cancer	0.000137	0.000836	CcSEcCtD
Cladribine—Diarrhoea—Ifosfamide—germ cell cancer	0.000137	0.000833	CcSEcCtD
Cladribine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000136	0.00083	CcSEcCtD
Cladribine—Body temperature increased—Cisplatin—germ cell cancer	0.000136	0.00083	CcSEcCtD
Cladribine—Fatigue—Etoposide—germ cell cancer	0.000136	0.000829	CcSEcCtD
Cladribine—RRM2—G1/S Transition—MYC—germ cell cancer	0.000136	0.00108	CbGpPWpGaD
Cladribine—Pain—Etoposide—germ cell cancer	0.000135	0.000822	CcSEcCtD
Cladribine—Constipation—Etoposide—germ cell cancer	0.000135	0.000822	CcSEcCtD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	0.000134	0.00106	CbGpPWpGaD
Cladribine—Haemoglobin—Methotrexate—germ cell cancer	0.000134	0.000815	CcSEcCtD
Cladribine—SLC28A3—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000134	0.00106	CbGpPWpGaD
Cladribine—Haemorrhage—Methotrexate—germ cell cancer	0.000133	0.000811	CcSEcCtD
Cladribine—Dizziness—Ifosfamide—germ cell cancer	0.000132	0.000805	CcSEcCtD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000132	0.00104	CbGpPWpGaD
Cladribine—Pharyngitis—Methotrexate—germ cell cancer	0.000132	0.000805	CcSEcCtD
Cladribine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000131	0.000801	CcSEcCtD
Cladribine—POLE—G1/S Transition—MYC—germ cell cancer	0.000131	0.00103	CbGpPWpGaD
Cladribine—Urethral disorder—Methotrexate—germ cell cancer	0.00013	0.000795	CcSEcCtD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00013	0.00103	CbGpPWpGaD
Cladribine—Feeling abnormal—Etoposide—germ cell cancer	0.00013	0.000792	CcSEcCtD
Cladribine—Nausea—Dactinomycin—germ cell cancer	0.00013	0.000789	CcSEcCtD
Cladribine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000129	0.000786	CcSEcCtD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	0.000128	0.00102	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—MYC—germ cell cancer	0.000128	0.00101	CbGpPWpGaD
Cladribine—Vomiting—Ifosfamide—germ cell cancer	0.000127	0.000774	CcSEcCtD
Cladribine—Hypersensitivity—Cisplatin—germ cell cancer	0.000127	0.000773	CcSEcCtD
Cladribine—Rash—Ifosfamide—germ cell cancer	0.000126	0.000768	CcSEcCtD
Cladribine—Dermatitis—Ifosfamide—germ cell cancer	0.000126	0.000767	CcSEcCtD
Cladribine—Erythema multiforme—Methotrexate—germ cell cancer	0.000126	0.000767	CcSEcCtD
Cladribine—Urticaria—Etoposide—germ cell cancer	0.000125	0.000764	CcSEcCtD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	0.000125	0.000988	CbGpPWpGaD
Cladribine—Abdominal pain—Etoposide—germ cell cancer	0.000125	0.00076	CcSEcCtD
Cladribine—Body temperature increased—Etoposide—germ cell cancer	0.000125	0.00076	CcSEcCtD
Cladribine—Eye disorder—Methotrexate—germ cell cancer	0.000124	0.000758	CcSEcCtD
Cladribine—Asthenia—Cisplatin—germ cell cancer	0.000124	0.000753	CcSEcCtD
Cladribine—Cardiac disorder—Methotrexate—germ cell cancer	0.000123	0.000752	CcSEcCtD
Cladribine—RRM2—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	0.000122	0.000962	CbGpPWpGaD
Cladribine—Angiopathy—Methotrexate—germ cell cancer	0.000121	0.000736	CcSEcCtD
Cladribine—Immune system disorder—Methotrexate—germ cell cancer	0.00012	0.000732	CcSEcCtD
Cladribine—Mediastinal disorder—Methotrexate—germ cell cancer	0.00012	0.000731	CcSEcCtD
Cladribine—Chills—Methotrexate—germ cell cancer	0.000119	0.000727	CcSEcCtD
Cladribine—Nausea—Ifosfamide—germ cell cancer	0.000119	0.000723	CcSEcCtD
Cladribine—POLE—S Phase—MYC—germ cell cancer	0.000119	0.000937	CbGpPWpGaD
Cladribine—Diarrhoea—Cisplatin—germ cell cancer	0.000118	0.000718	CcSEcCtD
Cladribine—Alopecia—Methotrexate—germ cell cancer	0.000118	0.000716	CcSEcCtD
Cladribine—POLE—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	0.000117	0.000924	CbGpPWpGaD
Cladribine—Mental disorder—Methotrexate—germ cell cancer	0.000117	0.00071	CcSEcCtD
Cladribine—Hypersensitivity—Etoposide—germ cell cancer	0.000116	0.000708	CcSEcCtD
Cladribine—Erythema—Methotrexate—germ cell cancer	0.000116	0.000706	CcSEcCtD
Cladribine—Malnutrition—Methotrexate—germ cell cancer	0.000116	0.000706	CcSEcCtD
Cladribine—RRM2—Mitotic G1-G1/S phases—MYC—germ cell cancer	0.000115	0.000906	CbGpPWpGaD
Cladribine—Asthenia—Etoposide—germ cell cancer	0.000113	0.00069	CcSEcCtD
Cladribine—ABCG2—brain—germ cell cancer	0.000113	0.000936	CbGeAlD
Cladribine—Back pain—Methotrexate—germ cell cancer	0.000112	0.000683	CcSEcCtD
Cladribine—Pruritus—Etoposide—germ cell cancer	0.000112	0.00068	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000111	0.000881	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—H2AFZ—germ cell cancer	0.000111	0.00088	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000111	0.00088	CbGpPWpGaD
Cladribine—RRM1—Metabolism—SLC2A3—germ cell cancer	0.000111	0.000875	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00011	0.00087	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—MYC—germ cell cancer	0.00011	0.00087	CbGpPWpGaD
Cladribine—Vomiting—Cisplatin—germ cell cancer	0.00011	0.000667	CcSEcCtD
Cladribine—RRM1—Metabolism—SLC22A3—germ cell cancer	0.000109	0.000862	CbGpPWpGaD
Cladribine—ABCG2—lymph node—germ cell cancer	0.000109	0.000905	CbGeAlD
Cladribine—RRM2—Cell Cycle—H2AFZ—germ cell cancer	0.000109	0.00086	CbGpPWpGaD
Cladribine—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000109	0.000859	CbGpPWpGaD
Cladribine—Rash—Cisplatin—germ cell cancer	0.000109	0.000662	CcSEcCtD
Cladribine—Dermatitis—Cisplatin—germ cell cancer	0.000109	0.000661	CcSEcCtD
Cladribine—Diarrhoea—Etoposide—germ cell cancer	0.000108	0.000658	CcSEcCtD
Cladribine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000107	0.000655	CcSEcCtD
Cladribine—Anaemia—Methotrexate—germ cell cancer	0.000107	0.000652	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000105	0.000834	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—H2AFZ—germ cell cancer	0.000104	0.000826	CbGpPWpGaD
Cladribine—Malaise—Methotrexate—germ cell cancer	0.000104	0.000636	CcSEcCtD
Cladribine—Dizziness—Etoposide—germ cell cancer	0.000104	0.000636	CcSEcCtD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000103	0.000811	CbGpPWpGaD
Cladribine—Nausea—Cisplatin—germ cell cancer	0.000102	0.000623	CcSEcCtD
Cladribine—Cough—Methotrexate—germ cell cancer	0.000101	0.000616	CcSEcCtD
Cladribine—Vomiting—Etoposide—germ cell cancer	0.0001	0.000611	CcSEcCtD
Cladribine—Rash—Etoposide—germ cell cancer	9.95e-05	0.000606	CcSEcCtD
Cladribine—Dermatitis—Etoposide—germ cell cancer	9.94e-05	0.000606	CcSEcCtD
Cladribine—Headache—Etoposide—germ cell cancer	9.89e-05	0.000602	CcSEcCtD
Cladribine—Myalgia—Methotrexate—germ cell cancer	9.86e-05	0.000601	CcSEcCtD
Cladribine—Arthralgia—Methotrexate—germ cell cancer	9.86e-05	0.000601	CcSEcCtD
Cladribine—Chest pain—Methotrexate—germ cell cancer	9.86e-05	0.000601	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	9.79e-05	0.000597	CcSEcCtD
Cladribine—Discomfort—Methotrexate—germ cell cancer	9.74e-05	0.000594	CcSEcCtD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	9.64e-05	0.000762	CbGpPWpGaD
Cladribine—Confusional state—Methotrexate—germ cell cancer	9.53e-05	0.000581	CcSEcCtD
Cladribine—NR5A1—Gene Expression—H2AFZ—germ cell cancer	9.45e-05	0.000747	CbGpPWpGaD
Cladribine—Infection—Methotrexate—germ cell cancer	9.39e-05	0.000572	CcSEcCtD
Cladribine—Nausea—Etoposide—germ cell cancer	9.37e-05	0.000571	CcSEcCtD
Cladribine—POLA1—G1/S Transition—MYC—germ cell cancer	9.3e-05	0.000736	CbGpPWpGaD
Cladribine—Nervous system disorder—Methotrexate—germ cell cancer	9.27e-05	0.000565	CcSEcCtD
Cladribine—Thrombocytopenia—Methotrexate—germ cell cancer	9.25e-05	0.000564	CcSEcCtD
Cladribine—Skin disorder—Methotrexate—germ cell cancer	9.18e-05	0.000559	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	9.15e-05	0.000723	CbGpPWpGaD
Cladribine—Hyperhidrosis—Methotrexate—germ cell cancer	9.14e-05	0.000557	CcSEcCtD
Cladribine—RRM2—Metabolism—SLC2A3—germ cell cancer	9.11e-05	0.000721	CbGpPWpGaD
Cladribine—Anorexia—Methotrexate—germ cell cancer	9.01e-05	0.000549	CcSEcCtD
Cladribine—RRM2—Metabolism—SLC22A3—germ cell cancer	8.98e-05	0.00071	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CRABP1—germ cell cancer	8.89e-05	0.000703	CbGpPWpGaD
Cladribine—Hypotension—Methotrexate—germ cell cancer	8.83e-05	0.000538	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.66e-05	0.000685	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	8.61e-05	0.000525	CcSEcCtD
Cladribine—Insomnia—Methotrexate—germ cell cancer	8.55e-05	0.000521	CcSEcCtD
Cladribine—DCK—Metabolism—SLC2A3—germ cell cancer	8.52e-05	0.000673	CbGpPWpGaD
Cladribine—Paraesthesia—Methotrexate—germ cell cancer	8.49e-05	0.000517	CcSEcCtD
Cladribine—POLA1—S Phase—MYC—germ cell cancer	8.44e-05	0.000668	CbGpPWpGaD
Cladribine—Dyspnoea—Methotrexate—germ cell cancer	8.43e-05	0.000513	CcSEcCtD
Cladribine—Somnolence—Methotrexate—germ cell cancer	8.4e-05	0.000512	CcSEcCtD
Cladribine—DCK—Metabolism—SLC22A3—germ cell cancer	8.39e-05	0.000663	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	8.32e-05	0.000658	CbGpPWpGaD
Cladribine—Decreased appetite—Methotrexate—germ cell cancer	8.22e-05	0.000501	CcSEcCtD
Cladribine—Gastrointestinal disorder—Methotrexate—germ cell cancer	8.16e-05	0.000497	CcSEcCtD
Cladribine—Fatigue—Methotrexate—germ cell cancer	8.15e-05	0.000497	CcSEcCtD
Cladribine—Pain—Methotrexate—germ cell cancer	8.08e-05	0.000493	CcSEcCtD
Cladribine—POLA1—Mitotic G1-G1/S phases—MYC—germ cell cancer	7.84e-05	0.00062	CbGpPWpGaD
Cladribine—Feeling abnormal—Methotrexate—germ cell cancer	7.79e-05	0.000475	CcSEcCtD
Cladribine—Gastrointestinal pain—Methotrexate—germ cell cancer	7.73e-05	0.000471	CcSEcCtD
Cladribine—Urticaria—Methotrexate—germ cell cancer	7.51e-05	0.000458	CcSEcCtD
Cladribine—Abdominal pain—Methotrexate—germ cell cancer	7.47e-05	0.000455	CcSEcCtD
Cladribine—Body temperature increased—Methotrexate—germ cell cancer	7.47e-05	0.000455	CcSEcCtD
Cladribine—POLA1—Cell Cycle—H2AFZ—germ cell cancer	7.44e-05	0.000588	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CRABP1—germ cell cancer	7.32e-05	0.000579	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.28e-05	0.000575	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.2e-05	0.000569	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.17e-05	0.000567	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.09e-05	0.000561	CbGpPWpGaD
Cladribine—Hypersensitivity—Methotrexate—germ cell cancer	6.96e-05	0.000424	CcSEcCtD
Cladribine—DCK—Metabolism—CRABP1—germ cell cancer	6.84e-05	0.000541	CbGpPWpGaD
Cladribine—Asthenia—Methotrexate—germ cell cancer	6.78e-05	0.000413	CcSEcCtD
Cladribine—NR5A1—Generic Transcription Pathway—MYC—germ cell cancer	6.78e-05	0.000536	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.71e-05	0.000531	CbGpPWpGaD
Cladribine—Pruritus—Methotrexate—germ cell cancer	6.69e-05	0.000407	CcSEcCtD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.61e-05	0.000523	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.54e-05	0.000517	CbGpPWpGaD
Cladribine—Diarrhoea—Methotrexate—germ cell cancer	6.47e-05	0.000394	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—MYC—germ cell cancer	6.26e-05	0.000495	CbGpPWpGaD
Cladribine—Dizziness—Methotrexate—germ cell cancer	6.25e-05	0.000381	CcSEcCtD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.09e-05	0.000482	CbGpPWpGaD
Cladribine—Vomiting—Methotrexate—germ cell cancer	6.01e-05	0.000366	CcSEcCtD
Cladribine—Rash—Methotrexate—germ cell cancer	5.96e-05	0.000363	CcSEcCtD
Cladribine—Dermatitis—Methotrexate—germ cell cancer	5.95e-05	0.000363	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.94e-05	0.00047	CbGpPWpGaD
Cladribine—Headache—Methotrexate—germ cell cancer	5.92e-05	0.000361	CcSEcCtD
Cladribine—Nausea—Methotrexate—germ cell cancer	5.61e-05	0.000342	CcSEcCtD
Cladribine—POLE2—Cell Cycle—MYC—germ cell cancer	5.6e-05	0.000443	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—HRAS—germ cell cancer	5.01e-05	0.000396	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.88e-05	0.000386	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—germ cell cancer	4.6e-05	0.000364	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MYC—germ cell cancer	4.2e-05	0.000332	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MYC—germ cell cancer	4.03e-05	0.000319	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MYC—germ cell cancer	3.76e-05	0.000297	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MYC—germ cell cancer	3.61e-05	0.000285	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC2A3—germ cell cancer	3.41e-05	0.00027	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC2A3—germ cell cancer	3.37e-05	0.000267	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC22A3—germ cell cancer	3.36e-05	0.000265	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	3.36e-05	0.000265	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC22A3—germ cell cancer	3.32e-05	0.000263	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	3.32e-05	0.000263	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MYC—germ cell cancer	3.26e-05	0.000258	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC2A3—germ cell cancer	3.14e-05	0.000249	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC22A3—germ cell cancer	3.1e-05	0.000245	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—AVP—germ cell cancer	3.1e-05	0.000245	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—germ cell cancer	3.09e-05	0.000244	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—germ cell cancer	2.96e-05	0.000234	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MYC—germ cell cancer	2.87e-05	0.000227	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CRABP1—germ cell cancer	2.74e-05	0.000216	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CRABP1—germ cell cancer	2.71e-05	0.000214	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MYC—germ cell cancer	2.57e-05	0.000203	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CRABP1—germ cell cancer	2.52e-05	0.0002	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	2.43e-05	0.000192	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	2.27e-05	0.000179	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—germ cell cancer	2.11e-05	0.000167	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—HRAS—germ cell cancer	1.86e-05	0.000147	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—HRAS—germ cell cancer	1.74e-05	0.000137	CbGpPWpGaD
